Journal of Cardiovascular Disease Research
Glycated Albumin - Biomarker for Glycaemic Control and Prognostic Factor in Chronic Kidney Disease Patients
Ranjithkanna M, Rajesh N , Velvizhi M , Thirunavukarasu MR
JCDR. 2023: 698-704
Abstract
Background: Chronic kidney disease is a public health problem of global concern. In HD patients, GA seems more reliable because it is not influenced by the erythrocyte lifespan or erythropoietin and iron therapy, so it could serve as an alternative marker for glycemic control in these patients. Efficacy for glycemic control in HD patients has not yet been firmly established because most studies have examined the correlation between GA and the mean of random serum glucose concentrations instead of continuous glucose monitoring. Aims and objectives: To assess the role of glycated albumin as a biochemical marker in glycemic control in chronic kidney disease patients (G5D) on hemodialysis.
» PDF